Search In this Thesis
   Search In this Thesis  
العنوان
IBD: Impact on scores of quality of life, depression and anxiety in patients with inflammatory bowel disease, single center study/
المؤلف
Omar,Yasmine Nabil Abd El-Rahman
هيئة الاعداد
باحث / ياسمين نبيل عبد الرحمن عمر
مشرف / محمد عوض محمد عوض منصور
مشرف / احمد فؤاد حلمى شريف
مشرف / لبنى ابو بكر اسماعيل عزام
تاريخ النشر
2023
عدد الصفحات
252.p:
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
الأمراض المعدية
تاريخ الإجازة
1/1/2023
مكان الإجازة
جامعة عين شمس - كلية الطب - Tropical Medicine
الفهرس
Only 14 pages are availabe for public view

from 252

from 252

Abstract

Inflammatory bowel disease (IBD) is a group of chronic relapsing inflammatory conditions of the gastrointestinal tract. Inflammatory bowel disease has a substantial impact on quality of life. It causes considerable personal, emotional, and social burdens. The impact of IBD on quality of life places a significant burden on the patient and caregivers. The study assessed the impact of inflammatory bowel disease and disease activity on quality of life of the patients.
This cross-section study was conducted on 88 patients with inflammatory bowel disease who attended the IBD Clinic, Ain Shams University Hospitals. An informed consent was obtained from each patient. All patients were subjected to clinical assessment, laboratory investigations, colonoscopy, assessment of disease activity and assessment of quality of life using PCASEE score.
The eighty-eight inflammatory bowel disease patients were divided into: G1: (CD) Crohn’s disease group 40 (45.5%) patients, and G2: ulcerative colitis (UC) group 48 (54.5%) patients. They were 39 (44.3%) males and 49 (55.7 %) females, with ages ranged between 19 and 52 years old (mean 33).
The result showed negative significant correlation between clinical and endoscopic activity in UC group measured by simple clinical colitis activity index and Mayo score respectively and quality of life scores in the patients with P <0.001. In CD, there was negative significant correlation between quality of life and clinical disease activity measured by Crohn’s disease activity index with P <0.001, but without endoscopic activity. There was no significant effect of inflammatory bowel disease on quality of life of the patients especially during disease activity.